158 related articles for article (PubMed ID: 32258980)
1. Bevacizumab-associated intestinal perforation and perioperative complications in patients receiving bevacizumab.
Yoshimoto T; Yoshikawa K; Higashijima J; Miyatani T; Tokunaga T; Nishi M; Takasu C; Kashihara H; Takehara Y; Shimada M
Ann Gastroenterol Surg; 2020 Mar; 4(2):151-155. PubMed ID: 32258980
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal perforation associated with bevacizumab in metastatic colorectal cancer.
Fang K; Wang J; Yuan J; Sui C; Zhi J; Xia Y; Sun M
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1952. PubMed ID: 38258341
[TBL] [Abstract][Full Text] [Related]
3. Postoperative complications following neoadjuvant bevacizumab treatment for advanced colorectal cancer.
Yoshioka Y; Uehara K; Ebata T; Yokoyama Y; Mitsuma A; Ando Y; Nagino M
Surg Today; 2014 Jul; 44(7):1300-6. PubMed ID: 23942819
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab.
Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; Mckendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L
World J Gastroenterol; 2015 May; 21(17):5352-8. PubMed ID: 25954110
[TBL] [Abstract][Full Text] [Related]
5. Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database.
Ueda A; Watari H; Mandai M; Fukuhara S; Sugitani Y; Ogino K; Kamijima S; Enomoto T
J Gynecol Oncol; 2022 Nov; 33(6):e78. PubMed ID: 36245228
[TBL] [Abstract][Full Text] [Related]
6. Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma.
Diaz JP; Tew WP; Zivanovic O; Konner J; Sabbatini PJ; dos Santos LA; Abu-Rustum NR; Chi DS; Aghajanian C; Barakat RR
Gynecol Oncol; 2010 Mar; 116(3):335-9. PubMed ID: 20004956
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of metal stents for malignant colonic obstruction in patients treated with bevacizumab.
Lee JH; Emelogu I; Kukreja K; Ali FS; Nogueras-Gonzalez G; Lum P; Coronel E; Ross W; Raju GS; Lynch P; Thirumurthi S; Stroehlein J; Wang Y; You YN; Weston B
Gastrointest Endosc; 2019 Jul; 90(1):116-124. PubMed ID: 30797835
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab-induced perforation of the gastrointestinal tract: clinical and radiographic findings in 11 patients.
Borofsky SE; Levine MS; Rubesin SE; Tanyi JL; Chu CS; Lev-Toaff AS
Abdom Imaging; 2013 Apr; 38(2):265-72. PubMed ID: 22627832
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab-related gastrointestinal perforation in patients with three or more prior chemotherapy regimens: A real-world experience.
Matsumiya H; Todo Y; Yamazaki H; Shimada C; Minobe S; Kato H
Taiwan J Obstet Gynecol; 2020 May; 59(3):377-380. PubMed ID: 32416883
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant oxaliplatin and capecitabine and bevacizumab without radiotherapy for poor-risk rectal cancer: N-SOG 03 Phase II trial.
Uehara K; Hiramatsu K; Maeda A; Sakamoto E; Inoue M; Kobayashi S; Tojima Y; Yoshioka Y; Nakayama G; Yatsuya H; Ohmiya N; Goto H; Nagino M
Jpn J Clin Oncol; 2013 Oct; 43(10):964-71. PubMed ID: 23935207
[TBL] [Abstract][Full Text] [Related]
11. [Analysis on operational safety of chronic radiation intestinal injury].
He YJ; Ma TH; Zhu MM; Huang XY; Kuang YY; Wang HM; Qin QY; Huang BJ; Wang JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1034-1040. PubMed ID: 31770834
[No Abstract] [Full Text] [Related]
12. Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study.
Petrillo M; Paris I; Vizzielli G; Amadio G; Cosentino F; Salutari V; Scambia G; Fagotti A
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S952-8. PubMed ID: 26036187
[TBL] [Abstract][Full Text] [Related]
13. A Population-Based Study of Complications After Colorectal Surgery in Patients Who Have Received Bevacizumab.
Baxter NN; Fischer HD; Richardson DP; Urbach DR; Bell CM; Rochon P; Brade A; Earle CC
Dis Colon Rectum; 2018 Mar; 61(3):306-313. PubMed ID: 29420426
[TBL] [Abstract][Full Text] [Related]
14. [Two Cases of Bowel Perforation during Chemotherapy with Bevacizumab to Metastatic Rectal Cancer].
Miyake Y; Ikeda K; Murakami M; Oka Y; Nezu R; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2015 Dec; 42 Suppl 1():75-8. PubMed ID: 26809419
[TBL] [Abstract][Full Text] [Related]
15. "Spontaneous," delayed colon and rectal anastomotic complications associated with bevacizumab therapy.
August DA; Serrano D; Poplin E
J Surg Oncol; 2008 Feb; 97(2):180-5. PubMed ID: 18095268
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study.
Yu X; Wang QX; Xiao WW; Chang H; Zeng ZF; Lu ZH; Wu XJ; Chen G; Pan ZZ; Wan DS; Ding PR; Gao YH
Cancer Commun (Lond); 2018 May; 38(1):24. PubMed ID: 29784042
[TBL] [Abstract][Full Text] [Related]
17. [Surgical management of bevacizumab-associated peritonitis due to perforation].
Kube R; Meyer F; Bien N; Schmidt C; Mroczkowski P; Dalicho S; Lippert H
Zentralbl Chir; 2009 Sep; 134(5):462-7. PubMed ID: 19757347
[TBL] [Abstract][Full Text] [Related]
18. Abdominal emergency surgery in patients with hematological malignancies: a retrospective single-center analysis.
von Kroge PH; Duprée A; Mann O; Izbicki JR; Wagner J; Ahmadi P; Weidemann S; Adjallé R; Kröger N; Bokemeyer C; Fiedler W; Modemann F; Ghandili S
World J Emerg Surg; 2023 Feb; 18(1):12. PubMed ID: 36747231
[TBL] [Abstract][Full Text] [Related]
19. Intestinal perforation in colorectal cancers treated with bevacizumab (Avastin).
Choi YI; Lee SH; Ahn BK; Baek SU; Park SJ; Kim YS; Shin SH
Cancer Res Treat; 2008 Mar; 40(1):33-5. PubMed ID: 19688063
[TBL] [Abstract][Full Text] [Related]
20. [A Case of Diverticular Perforation of Sigmoid Colostomy during FOLFIRI plus BevacizumabTreatment].
Watanabe M; Sumi T; Udou R; Enomoto M; Matsudo T; Tachibana S; Mimuro A; Katsumata K; Tsuchida A
Gan To Kagaku Ryoho; 2019 Jan; 46(1):148-150. PubMed ID: 30765670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
